Obio Technology (Shanghai) Corp., Ltd. (SHA:688238)

Market Cap	4.47B +47.1%
Revenue (ttm)	244.64M -2.8%
Net Income	-294.16M
EPS	-0.46
Shares Out	630.31M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,459,321
Average Volume	9,417,168
Open	7.15
Previous Close	7.15
Day's Range	7.07 - 7.20
52-Week Range	4.49 - 9.20
Beta	0.59
RSI	44.99
Earnings Date	Apr 21, 2026

About SHA:688238

Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China. The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials. It also provides CDMO services encompassing process development, analytical meth...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2013
• Employees: 678
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688238

Financial Performance

In 2024, SHA:688238's revenue was 248.15 million, an increase of 21.16% compared to the previous year's 204.81 million. Losses were -321.81 million, 151.5% more than in 2023.